August 26, 2014—This document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions is a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, the European Heart Rhythm Association (EHRA), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and the European Association of Acute Cardiac Care (ACCA).
The Heart Rhythm Society endorsed the document in June 2014.
HRS Endorsed
- Yes
Topic
- Atrial Arrhythmias
- Atrial Fibrillation
- Clinical Topics
Resource Type
- Clinical Guidelines
Related Resources
Clinical Guidelines
2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion
Evidence-based guidance from SCAI and HRS on the use of transcatheter left atrial appendage occlusion for stroke prevention in atrial fibrillation, including patient selection, imaging,…
August 4, 2025
Clinical Guidelines
2024 HRS Expert Consensus Statement on Arrhythmias in the Athlete: Evaluation, Treatment, and Return to Play
Guidance on evaluating and managing arrhythmias in athletes, including risk stratification, treatment options, and return-to-play decision-making.
May 17, 2024
Clinical Guidelines
2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
EHRA/HRS/APHRS/LAHRS consensus on AF ablation, guiding patient selection, procedural best practices, and use of emerging technologies.
April 8, 2024